期刊文献+

大豆异黄酮对代谢综合征模型大鼠抗动脉粥样硬化作用的机制 被引量:9

Mechanism of Soybean Isoflavones on Anti-Atherosclerosis in Metabolic Syndrome Rats
下载PDF
导出
摘要 目的观察大豆异黄酮对代谢综合征大鼠肝脏过氧化体增殖物激活型受体α的表达以及主动脉核因子κB、血管细胞粘附分子1表达的影响,探讨大豆异黄酮抗动脉粥样硬化的可能机制。方法将60只SD大鼠随机分为普通饲料组(对照组,10只)和高脂高盐高糖饲料组(50只),20周后成功复制代谢综合征模型大鼠37只,将37只代谢综合征模型大鼠随机分为模型组(9只)和高、低剂量大豆异黄酮组(各10只)以及非诺贝特组(8只),灌药4周后,生物化学法测血脂,实时荧光定量PCR测定各组大鼠肝脏过氧化体增殖物激活型受体α mRNA的表达情况,免疫组织化学法测定各组大鼠主动脉核因子κB和血管细胞粘附分子1的表达。结果与模型组相比,高剂量大豆异黄酮组血清甘油三酯、总胆固醇以及低密度脂蛋白水平显著降低(P<0.01),并且肝脏过氧化体增殖物激活型受体α mRNA的表达显著增加(P<0.01);与对照组比,模型组大鼠主动脉核因子κB和血管细胞粘附分子1均显著增加(P<0.01),高剂量大豆异黄酮可降低大鼠主动脉核因子κB和血管细胞粘附分子1的表达(P<0.01)。结论大豆异黄酮可以调节代谢综合征模型大鼠的血脂,降低动脉粥样硬化因子核因子κB和血管细胞粘附分子1的水平,具有抗动脉粥样硬化形成作用,其机制可能与上调过氧化体增殖物激活型受体α mRNA的表达有关。 Aim To observe the therapeutic effect of soybean isoflavones (SI) on the expression of peroxisome proliferator activated receptor α (PPARα), nuclear factor-kappa B(NF-κB), vascular cell adhesion molecule-1(VCAM-1), and investigate its mechanism of anti-atherosclerosis in metabolic syndrome rats. Methods Sixty male SD rats were randomly divided into normal diet group (n=10)and high-fat diet group (n=50)to induce metabolic syndrome model. Rats in high-fat diet group were fed with high-lipid high-salt high-sug...
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第12期928-932,共5页 Chinese Journal of Arteriosclerosis
基金 黑龙江省博士后基金资助项目(LBH-Z05229)
关键词 中药学 代谢综合征 大豆异黄酮 过氧化体增殖物激活型受体Α 动脉粥样硬化 核因子ΚB 血管细胞粘附分子1 Metabolic Syndrome Soybean Isoflavones Peroxisome Proliferator Activated Receptor α Atherosclerosis Nuclear Factor-Kappa B Vascular Cell Adhesion Molecule-1
  • 相关文献

参考文献2

  • 1胡榕,吴可贵.核因子κB在心血管疾病中的作用的研究现状[J].中国动脉硬化杂志,2004,12(5):604-606. 被引量:17
  • 2Rai Ajit K. Srivastava,Ravi Jahagirdar,Salman Azhar,Somesh Sharma,Charles L. Bisgaier. Peroxisome proliferator-activated receptor-α selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice[J] 2006,Molecular and Cellular Biochemistry(1-2):35~50

二级参考文献28

  • 1Speir E. Cytomegalovirus gene regulation by reactive oxygen species.Agents in Atherosclerosis. Ann NY Acad Sci, 2000, 899 (3): 363-374
  • 2Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest, 1996, 97 (7): 1 715-722
  • 3Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med, 1999, 340: 115-126
  • 4Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappa B activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol, 2000, 20 (3): 645-651
  • 5Tiran A, Gruber HJ, Graier WF, Wagner AH, Van Leeuwen EB, Tiran B. Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation,cytokine expression,and bacterial development in human endothelial cells. Arterioscler Thromb Vasc Biol,2002,22(7):1 075-080
  • 6Wilson SH, Best PJ, Edwards WD, Holmes DR Jr, Carlson PJ, Celermajer DS, et al. Nuclear factor-kappa B immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis, 2002, 160 (1): 147-153
  • 7Ruiz-Ortega M, Lorenzo O, Ruperez M, Suzuki Y, Egido J. Angiotensin Ⅱ activates nuclear transcription factor- kappa B in aorta of normal rats and in vascular smooth muscle cells of AT1 knock out mice. Nephrol Dial Transplant, 2001, 16 (suppl 1): 27-33
  • 8Purcell NH, Tang G-L, Yu C-F, Frank Mercurio, Joseph A. Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. PNAS, 2001, 98 (12): 6 668-673(2Pt2): H543-552
  • 9Li C, Browder W, Kao RL. Early activation of transcription factor NF-kappa B during ischemia in perfused rat heart. Am J Physiol, 1999, 276
  • 10Kalra D, Baumgarten G, Dibbs Z, Seta Y, Sivasubramanian N, Mann DL. Nitric oxide provokes tumor necrosis factor alpha expression in adult feline myocardium through a cGMP-dependent pathway. Circulation, 2000, 102 (11): 1 302-307

共引文献16

同被引文献110

引证文献9

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部